News Release

Sihoun Hahn, M.D., Ph.D., F.A.C.M.G., is the 2009-2010 Luminex/ACMGF Award recipient

$100,000 award presented at the 2009 Annual Clinical Genetics Meeting of the American College of Medical Genetics

Grant and Award Announcement

American College of Medical Genetics and Genomics

The American College of Medical Genetics Foundation (ACMGF) recently awarded Dr. Sihoun Hahn of Seattle Children's Hospital and the University of Washington School of Medicine the 2009-2010 Luminex/ACMGF Award at the American College of Medical Genetics 2009 Annual Clinical Genetics Meeting in Tampa, FL. The award includes a $100,000 grant and is aimed at the promotion of safe and effective genetic testing and services, including the development of research guidelines.

"Medical geneticists play a vital role in translating genetic research into medical services and in ensuring the safe integration of genetics into health care and public health. The Luminex/ACMGF Award recognizes this crucial role of medical geneticists by supporting an individual in undertaking activities that promote the highest levels of safety and effectiveness in genetic testing and genetic services," said R. Rodney Howell, MD, FACMG, President of the ACMGF.

Dr. Hahn is a member of the advisory committee for newborn screening in Washington state and the medical advisory committee for the Wilson Disease Association. He is Director, Biochemical Genetics Program and Professor, Department of Pediatrics, Division of Genetics and Genomic Medicine at the University of Washington School of Medicine and Director, Biochemical and Molecular Genetics Laboratory, Seattle Children's Hospital.

###

About the American College of Medical Genetics

Founded in 1991, the American College of Medical Genetics (www.acmg.net) advances the practice of medical genetics by providing education, resources and a voice for more than 1400 biochemical, clinical, cytogenetic, medical and molecular geneticists, genetic counselors and other health care professionals committed to the practice of medical genetics. ACMG's activities include the development of laboratory and practice standards and guidelines, advocating for quality genetic services in health care and in public health, and promoting the development of methods to diagnose, treat and prevent genetic disease. Genetics in Medicine, published monthly, is the official ACMG peer-reviewed journal. ACMG's website (www.acmg.net) offers a variety of resources including Policy Statements, Practice Guidelines, Educational Resources, and a Medical Geneticist Locator. The educational and public health programs of the American College of Medical Genetics are dependent upon charitable gifts from corporations, foundations, and individuals. The American College of Medical Genetics Foundation (www.acmgfoundation.org) is a 501 (c)(3) not-for-profit organization dedicated to funding the College's diverse efforts to translate genes into health.

About Luminex Corporation

Luminex Corporation develops, manufactures and markets proprietary biological testing technologies with applications throughout the diagnostic and life sciences industries. The Company's xMAP® multiplex solutions include an open-architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics markets. The Company's xMAP Technology is sold worldwide and is already in use in leading clinical laboratories as well as major pharmaceutical, diagnostic and biotechnology companies. Further information on Luminex Corporation or xMAP Technology can be obtained at www.luminexcorp.com.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.